VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX)
CUSIP: 928661107
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 159,533,673
- Total 13F shares
- 6,193,332
- Share change
- +296,202
- Total reported value
- $15,049,871
- Put/Call ratio
- 34%
- Price per share
- $2.43
- Number of holders
- 32
- Value change
- +$949,239
- Number of buys
- 13
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 928661107?
CUSIP 928661107 identifies VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 928661107:
Top shareholders of VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. |
13F
|
Company |
2%
|
3,256,745
|
$4,429,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.34%
|
537,939
|
$732,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.32%
|
503,270
|
$685,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.24%
|
378,354
|
$515,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
288,356
|
$392,000 | — | 30 Sep 2022 | |
| Bank Julius Baer & Co. Ltd, Zurich |
13F
|
Company |
0.09%
|
147,632
|
$201,000 | — | 30 Sep 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
126,100
|
$171,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.07%
|
115,323
|
$157,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
103,620
|
$141,000 | — | 30 Sep 2022 | |
| Cowen Prime Advisors LLC |
13F
|
Company |
0.06%
|
96,631
|
$131,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
74,668
|
$102,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
60,847
|
$83,000 | — | 30 Sep 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
37,564
|
$51,000 | — | 30 Sep 2022 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
34,366
|
$47,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
24,486
|
$33,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
21,734
|
$30,000 | — | 30 Sep 2022 | |
| Jason Bradley Terrell MD |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
33,192
|
$27,550 | — | 03 Aug 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
17,906
|
$24,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
15,458
|
$21,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
15,384
|
$21,000 | — | 30 Sep 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
10,500
|
$14,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
8,252
|
$11,000 | — | 30 Sep 2022 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0%
|
5,000
|
$7,000 | — | 30 Sep 2022 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0%
|
4,225
|
$6,000 | — | 30 Sep 2022 | |
| CREDIT AGRICOLE S A |
13F
|
Individual |
0%
|
4,000
|
$5,000 | — | 30 Sep 2022 | |
| Founders Capital Management |
13F
|
Company |
0%
|
4,000
|
$5,000 | — | 30 Sep 2022 | |
| CarsonAllaria Wealth Management, Ltd. |
13F
|
Company |
0%
|
2,840
|
$4,000 | — | 30 Sep 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
2,363
|
$3,000 | — | 30 Sep 2022 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
1,000
|
$1,000 | — | 30 Sep 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
265
|
$360 | — | 30 Sep 2022 |
Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q4 2022
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.